Slide 1: Cegedim H1 2014 Results
ne \ Strength
Slide 2: Safe Harbor Statement
Safe Harbor This presentation contains forward-looking Statement statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward- looking statements involve risk and uncertainty. Forward-looking statements represent the comp
Slide 3: Business & Strategy Review
EE STRATE SS & Strategy Review eu cegedim
Slide 4: First Half Key 2014 Takeaways
First Half Key 2014 Takeaways This document should not be distributed without Cegedim authorization – Copyright 2014 4
Slide 5: First Half 2014 Key Figures
First Half 2014 Key Figures This document should not be distributed without Cegedim authorization – Copyright 2014 5
Slide 6: CRM & Strategic Data Review
CRM & Strategic Data Review Continued margin improvement thanks to the: • On-going restructuring measures • Growth in products and services linked to the OneKey database • Growth in Compliance activities • Stabilization of the market research activity This document should not be distributed without
Slide 7: Healthcare Professionals Review
Healthcare Professionals Review • Software for UK Doctors: double-digit decline in revenue • Demanding comparison • Software for French pharmacists: high single-digit decline in revenue • Despite uncertainty related to government announcement regarding certain professions, the order book is developi
Slide 8: Insurance & Services Review
Insurance & Services Review • Transition from a perpetual license model to a SaaS model at Cegedim Global Payments • Significant investment in Kadrige • Profitability increase thanks to: • Activity for Health Insurance companies • Cegedim SRH This document should not be distributed without Cegedim a
Slide 9: GERS Activities & Reconciliation Review
GERS Activities & Reconciliation Review • Virtual stability of corporate costs • Gradual return to profitability at GERS activities This document should not be distributed without Cegedim authorization – Copyright 2014 9
Slide 10: 2014 Outlook
2014 Outlook This document should not be distributed without Cegedim authorization – Copyright 2014 10
Slide 11: Proposed IMS Health Transaction
Proposed IMS Health Transaction This document should not be distributed without Cegedim authorization – Copyright 2014 11
Slide 12: Proposed IMS Health Transaction
Proposed IMS Health Transaction This document should not be distributed without Cegedim authorization – Copyright 2014 12
Slide 13: First Half 2014 Financial Situation
First Half 2014 Financial Situation
Slide 14: Currency Impact and Business Seasonality
Currency Impact and Business Seasonality This document should not be distributed without Cegedim authorization – Copyright 2014 14
Slide 15: Revenue per Division
Revenue per Division This document should not be distributed without Cegedim authorization – Copyright 2014 15
Slide 16: From Revenue to EBITDA
From Revenue to EBITDA This document should not be distributed without Cegedim authorization – Copyright 2014 16
Slide 17: EBITDA per Division
EBITDA per Division This document should not be distributed without Cegedim authorization – Copyright 2014 17
Slide 18: From EBITDA to EBIT
From EBITDA to EBIT This document should not be distributed without Cegedim authorization – Copyright 2014 18
Slide 19: From EBIT to Net Profit
From EBIT to Net Profit This document should not be distributed without Cegedim authorization – Copyright 2014 19
Slide 20: Solid Financial Structure
Solid Financial Structure This document should not be distributed without Cegedim authorization – Copyright 2014 20
Slide 21: Free Cash Flow Analysis
Free Cash Flow Analysis This document should not be distributed without Cegedim authorization – Copyright 2014 21
Slide 22: Net Debt Trend
Net Debt Trend This document should not be distributed without Cegedim authorization – Copyright 2014 22
Slide 23: April 2014 Refinancing
April 2014 Refinancing This document should not be distributed without Cegedim authorization – Copyright 2014 23
Slide 24: Strong Liquidity Position
Strong Liquidity Position This document should not be distributed without Cegedim authorization – Copyright 2014 24
Slide 25: Our IR App is now available
Our IR App is now available This document should not be distributed without Cegedim authorization – Copyright 2014 25
Slide 26: Next Event
Next Event This document should not be distributed without Cegedim authorization – Copyright 2014 26
Slide 27: Appendix
Appendix Innovation STRATEGY Strength ih. : eu cegedim
Slide 28: Revenue & Organic Growth Calculation
Revenue & Organic Growth Calculation CRM & Strategic Healthcare Insurance & GERS Activities & Q2‐2014 Group Data Professionals Services Reconciliation Q2 2013 Revenue a 101,845 75,672 39,850 6,996 224,363 Impact of disposals 0 0 0 0 0 Q2 2013 Revenue before impact of disposals 101,845 75,672 39,850
Slide 29: RCF Covenant Calculation at June 30, 2014
RCF Covenant Calculation at June 30, 2014 June 30, Senior Net Debt in € thousands 2014 Consolidated total debt (A) 539,849 Employee profit sharing plan (B) 9,109 Subordinated Shareholder Loans (C) 45,094 Total active cash (D) 79,834 Senior Net Debt (A‐B‐C‐D) 405,812 Relevant Interest In € thousands
Slide 30: 2014 Financial Agenda
2014 Financial Agenda This document should not be distributed without Cegedim authorization – Copyright 2014 30
Slide 31: We welcome your questions and comments
We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer Head of Investor Relations Janeryk.umiastowski@cegedim.com www.cegedim.com/finance TEL: +33 (0) 1 49 09 33 36